Top Markets
Coin of the day
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Rang în acțiuni #13831
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Preț acțiune
$4.36
Ultima sincronizare: 2026-08-31
Capitalizare de piață
$457.32M
Schimbare (1 zi)
0.69%
Schimbare (1 an)
289.29%
Țară
US
Tranzacționează Relmada Therapeutics, Inc. (RLMD)

Categorie

Istoricul spliturilor pentru Relmada Therapeutics, Inc. (RLMD)
Acțiunea Relmada Therapeutics, Inc. (simbol: RLMD) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Sep 01, 2026.
O acțiune RLMD cumpărată înainte de Sep 01, 2026 este echivalentă astăzi cu 0 acțiuni RLMD.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH